Clinical Trial Participation
The success of any clinical trial depends on the willingness of individuals to participate.
Clinical trials at Banner Alzheimer's Institute (BAI) require a broad mix of study participants, including those with Alzheimer's disease and memory disorders as well as those who do not yet have dementia but show early signs of memory loss.
Study participation for individuals with Alzheimer's or other dementias typically requires a commitment from the family or caregiver, since they play an integral role in the patient's ability to participate.
Participation in clinical trials at BAI enables patients to:
- Obtain access to investigational treatments before they become more widely available
- Receive examinations and tests associated with the study
- Contribute to the discovery of new treatments and prevention therapies
- Play an active role in their own health care
- Connect with an extensive network of support programs.
The participation requirements for each clinical trial are dictated by the study objectives. Generally, participants eligible for Alzheimer's disease studies at BAI are required to:
- Sign consent forms for the specific study
- Travel to and from BAI for all visits required as part of the study
- Receive physical examinations and/or laboratory tests
- Participate in memory and thinking tests
- Undergo medical procedures such as lumbar puncture, MRI, CT and PET scans.
Learn more about your eligibility for participation in clinical trials being conducted at Banner Alzheimer's Institute.